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An entirely new method for the dynamic kinetic resolution
of a racemic, 2-methyl substituted, unsymmetrical 1,3-dike-
tone via enzymatic reduction to give an enantiomerically
pure compound is introduced.
The dynamic kinetic resolution of a-substituted b-keto esters by
chemical1 or biocatalytical2 reduction is particularly useful due
to the simultaneous introduction of two stereogenic centres into
the molecule in combination with a theoretical maximum yield
of 100%. Although this method has proven broad applicability
in stereoselective synthesis, the corresponding dynamic kinetic
resolution of 2-substituted 1,3-diketones is rarely found in the
literature.3 Our aim is directed toward extending dynamic
kinetic resolution to enantio- and regioselective reduction of
alkyl-substituted 3,5-dioxoesters, which would enable the
introduction of up to four stereogenic centers by two consec-
utive reduction steps.
The attempted enantioselective ketone reduction of
3,5-dioxohexanoate esters by chemical methods4 or bio-
transformation5 usually results in complex mixtures of several
stereo- and regioisomeric products with one or both keto groups
reduced. We figured out that this difficult transformation can be
accomplished by using isolated enzymes to afford optically pure
5-hydroxy-3-oxohexanoates in high yield.6 Herein we wish to
report in preliminary form on the first enantio- and re-
gioselective enzymatic reduction of 4-alkyl-3,5-dioxohex-
anoates resulting in formation of one out of a total of 8
monoreduction and 8 bisreduction products.
tert-Butyl 4-methyl-3,5-dioxohexanoate (1) was prepared by
acylation of the bisenolate of tert-butyl 3-oxovalerate with
commercially available Weinreb acetamide.7 For the enzymatic
reduction recombinant alcohol dehydrogenase from Lactoba-
cillus brevis (recLBADH) was chosen, which has been cloned
and overexpressed in E. coli.8 recLBADH exhibits a broad
substrate range and considerable stability even towards highly
reactive compounds like 6-chloro-3,5-dioxohexanoates.6,8 Co-
factor (NADPH) regeneration succeeds via a coupled-substrate
process. Propan-2-ol (200 mM) was applied in excess to the
reaction mixture as an auxiliary substrate in order to shift the
equilibrium of the reaction towards the desired direction
(Scheme 1).9
NMR data of the major product (4S,5R)-2 which was
obtained in 66% isolated yield, clearly proved the regioselective
monoreduction of the keto group at C-5. Additionally, from
GC-MS data of the crude product after derivatisation with
(F3CCO)2O, pyridine, no evidence could be found for the
reduction of the keto group at C-3. In order to verify the
proposed absolute configuration and to enable precise determi-
nation of the enantiomeric excess, (4S,5R)-2 was transformed
through sodium borohydride reduction into lactone 4 via diol
(3RS,4S,5R)-3. Lactonisation and dehydration gave the un-
saturated lactone (5R,6R)-4 which is known in racemic form10
(Scheme 2).
As a standard a racemic 1:1 mixture of syn- and anti-lactone
rac-4 was synthesised from keto ester 5 by sodium borohydride
reduction, subsequent chain elongation, and, finally, lactone
formation as described above (Scheme 3). The four stereo-
isomers of syn/anti-rac-4, which were formed in equal amounts,
can be separated by HPLC on chiral stationary phase (Daicel
Chiracel OB).
An authentic sample of the enantiomeric syn-lactone (5S,6S)-
4 was synthesised by the same sequence starting from bakers’
yeast reduction of 5 via the known11 ethyl (2R,3S)-2-methyl-
3-hydroxybutyrate (2R,3S)-6 (Scheme 4).
The spectroscopic data (1H-NMR, 13C-NMR, MS) of
(5S,6S)-4 and of (5R,6R)-4, produced via enzymatic
(recLBADH) reduction of 1, are identical. Comparison of the
CSP-HPLC data of both lactones revealed the (4S,5R)-absolute
configuration for the product 2 of the recLBADH reduction.
This product is formed in almost enantiomerically pure form
(99.2% ee, HPLC data); the diastereomeric ratio of syn+anti
97+3 is likewise very high (NMR and HPLC data).
Scheme 1 Reagents and conditions: i, 1 (20 mM), propan-2-ol (200 mM),
NADP+ (1 mM), pH 6.5, recLBADH (360 U), 23 h, rt (66%).
Scheme 2 Reagents and conditions: i, NaBH4, EtOH, 0 °C; ii, cat. TsOH,
toluene, reflux, 2 h (60% over two steps).
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In summary, we have shown the regio- and enantioselective
reduction of tert-butyl 4-methyl-3,5-dioxohexanoate via dy-
namic kinetic resolution to give an almost enantiomerically and
diastereomerically pure compound introducing two stereogenic
centers can be done efficiently by enzyme-catalysed reduction.
This method represents a novel entry into the chemistry of
polypropionates based on a biomimetic approach via poly-
ketides. This method should be extendable towards dynamic
kinetic resolution of other 2-alkyl-substituted unsymmetrical
1,3-diketones.
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